The FDA suspends three Keytruda studies; drug and device makers gave $8 billion in payments to providers in 2016; Opdivo beat Yervoy in skin-cancer trial
Five things for pharma marketers to know: Friday, October 7, 2016
Another study finds doctors who receive gifts from drugmakers prescribe their drugs; Part D spending rose 17% in 2014; Mallinckrodt to open New Jersey site